3-(3,5-dioxo-4,5-dihydro-3H-(1,2,4)triazin-2-yl)-benzamide derivatives as P2X7-inhibitors for the treatment of inflammatory diseases
A Standard patent application filed on 19 December 2003 credited to Dombroski, Mark Anthony
;
Duplantier, Allen Jacob
Details
Application number :
2003285716
Application type :
Standard
Application status :
SEALED
Under opposition :
No
Proceeding type :
Invention title :
3-(3,5-dioxo-4,5-dihydro-3H-(1,2,4)triazin-2-yl)-benzamide derivatives as P2X7-inhibitors for the treatment of inflammatory diseases
Inventor :
Dombroski, Mark Anthony
;
Duplantier, Allen Jacob
Agent name :
Shelston IP
Address for service :
Level 21 60 Margaret Street Sydney NSW 2000 Australia
Filing date :
19 December 2003
Associated companies :
Applicant name :
Pfizer Products Inc.
Applicant address :
Eastern Point Road Groton CT 06340 United States of America